David Roth
CIK 1599014 · Chief Medical Officer · last filed 2024-11-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
19
Lifetime Open-Market Net
-$139.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Chief Medical Officer | 0 | $0.00 | $0 | -$139.8K | 18 | 2024-11-20 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Chief Medical Officer | — | $0.04 | — | $0 | 1 | 2015-01-16 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-11 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | SYRS | Tax (F) | −27,281 | -$30.6K | EDGAR |
| 2022-02-17 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2019-02-14 | SYRS | Grant (A) | +87,000 | $0 | EDGAR |
| 2018-02-21 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2017-02-13 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2015-01-16 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.